Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Opko Health Inc (NASDAQ: OPK) closed at $1.44 in the last session, down -0.69% from day before closing price of $1.45. In other words, the price has decreased by -$0.69 from its previous closing price. On the day, 2.74 million shares were traded. OPK stock price reached its highest trading level at $1.47 during the session, while it also had its lowest trading level at $1.39.
Ratios:
We take a closer look at OPK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.02 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.29.
On June 29, 2023, Barrington Research Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $2. On December 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $3.H.C. Wainwright initiated its Buy rating on December 15, 2022, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 08 ’25 when FROST PHILLIP MD ET AL bought 675,000 shares for $1.32 per share. The transaction valued at 891,000 led to the insider holds 214,676,448 shares of the business.
FROST PHILLIP MD ET AL bought 125,000 shares of OPK for $169,712 on Apr 10 ’25. The CEO & Chairman now owns 214,001,448 shares after completing the transaction at $1.36 per share. On Apr 08 ’25, another insider, FROST PHILLIP MD ET AL, who serves as the CEO & Chairman of the company, bought 125,000 shares for $1.48 each. As a result, the insider paid 184,650 and bolstered with 213,876,448 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPK now has a Market Capitalization of 1143047296 and an Enterprise Value of 1271507200. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.72 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at 1.915 whereas that against EBITDA is -7.356.
Stock Price History:
The Beta on a monthly basis for OPK is 1.49, which has changed by -0.02702701 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, OPK has reached a high of $2.04, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 5.48%, while the 200-Day Moving Average is calculated to be -1.95%.
Shares Statistics:
According to the various share statistics, OPK traded on average about 2.85M shares per day over the past 3-months and 3102880 shares per day over the past 10 days. A total of 779.78M shares are outstanding, with a floating share count of 358.61M. Insiders hold about 54.82% of the company’s shares, while institutions hold 27.86% stake in the company. Shares short for OPK as of 1756425600 were 32466072 with a Short Ratio of 11.38, compared to 1753920000 on 32768192. Therefore, it implies a Short% of Shares Outstanding of 32466072 and a Short% of Float of 6.9699995.
Earnings Estimates
As of right now, 6.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.27 and -$0.43 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.35, with 1 analysts recommending between -$0.35 and -$0.35.
Revenue Estimates
According to 5 analysts, the current quarter’s revenue is expected to be $165.74M. It ranges from a high estimate of $167.7M to a low estimate of $161.5M. As of the current estimate, Opko Health Inc’s year-ago sales were $173.6MFor the next quarter, 5 analysts are estimating revenue of $168.68M. There is a high estimate of $175.4M for the next quarter, whereas the lowest estimate is $152.5M.
A total of 5 analysts have provided revenue estimates for OPK’s current fiscal year. The highest revenue estimate was $649.8M, while the lowest revenue estimate was $620.76M, resulting in an average revenue estimate of $641.17M. In the same quarter a year ago, actual revenue was $713.1MBased on 6 analysts’ estimates, the company’s revenue will be $637.85M in the next fiscal year. The high estimate is $738.8M and the low estimate is $567.1M.
